BRIEF published on 01/28/2026 at 07:48, 2 days 16 hours ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 01/28/2026 at 07:43, 2 days 16 hours ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
BRIEF published on 12/19/2025 at 07:35, 1 month 11 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 1 month 11 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 4 months 13 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
PRESS RELEASE published on 09/17/2025 at 07:30, 4 months 13 days ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
BRIEF published on 09/04/2025 at 07:35, 4 months 26 days ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
PRESS RELEASE published on 09/04/2025 at 07:30, 4 months 26 days ago Inside Information / Other news releases Sensorion announces participation in the 60th Annual Inner Ear Biology Workshop presenting gene therapy research for hearing loss disorders Research Gene Therapy Sensorion Hearing Loss Disorders Inner Ear Biology Workshop
BRIEF published on 08/15/2025 at 07:35, 5 months 15 days ago Sensorion Strengthens its Liquidity Contract with Kepler Cheuvreux Liquidity Biotechnology Euronext Kepler Cheuvreux Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 5 months 15 days ago Inside Information / Other news releases Sensorion increases resources allocated to liquidity contract with Kepler Cheuvreux by €60,000 to enhance liquidity of shares on Euronext Paris. The move is in accordance with AMF Decision No. 2021-01 Euronext Paris Liquidity Contract Kepler Cheuvreux AMF Decision Sensorion
Published on 01/30/2026 at 23:00, 1 hour 40 minutes ago Avidian Gold Corp. Announces Director Resignation
Published on 01/30/2026 at 22:45, 1 hour 55 minutes ago Noram Lithium Announces Fully Allocated Non-Brokered Financing
Published on 01/30/2026 at 22:30, 2 hours 10 minutes ago Alta Copper Receives Court Approval for Proposed Acquisition by Fortescue
Published on 01/30/2026 at 14:00, 10 hours 40 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 22:00, 2 hours 40 minutes ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 4 hours 29 minutes ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 4 hours 30 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 4 hours 32 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 17:45, 6 hours 55 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 6 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 6 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 6 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
